Skip to main content
. 2021 Nov 25;22(23):12741. doi: 10.3390/ijms222312741
15-PGDH 15-hydroxyprostaglandin dehydrogenase
AIs Aromatase inhibitors
AKT Protein kinase B
ALDH1
ATRA
Aldehyde dehydrogenase 1
All-trans-retinoic acid
BC Breast cancer
Bcl-2 B cell CLL/lymphoma-2
BCSC Breast cancer stem cells
CCND1 Cyclin D1
CD Cluster of differentiation
CDK Cyclin-dependent kinases
COX Cyclooxygenase
CSCs
DBP
Cancer stem cells
Vitamin D binding protein
DNMT DNA methyltransferase
EAG1 Ether-a-go-go-1 potassium channel
EGFR Epidermal growth factor receptor
EMT Epithelial-mesenchymal transition
EP Prostaglandin E receptor
ER Estrogen receptor
ERK Extracellular signal-regulated kinases
FP Prostaglandin F receptor
HDAC Histone deacetylases
HDACI Histone deacetylase inhibitors
HER2 Epidermal growth factor receptor type 2
HERG Human EAG related genes
i.v. Intravenous
IGF-1 Insulin-like growth factor 1
IGFBP-3 Insulin-like growth factor binding protein 3
JAK Janus kinase
MAPK Mitogen-activated protein kinase
MDM2 Murine double minute 2
MMP Metalloproteinase
MTD Maximum tolerated dose
NFκβ Nuclear factor-kappa beta
NMU N-methylnitrosourea
NSAIDs Nonsteroidal anti-inflammatory drugs
OVX Ovariectomized
PARP Poly (ADP-ribose) polymerase
PI3K Phosphatidylinositol 3-kinase
PLA Phospholipase A2
PR Progesterone receptor
QDR Days a week
RARs Retinoid acid receptors
RAREs Retinoic-Acid-Response-Elements
ROS Reactive oxygen species
RXR Retinoid-X receptor
SERD Selective estrogen receptor down-
SERM Selective estrogen receptor modulator
STAT Activator of transcription
TGF-β1 Transforming growth factor-beta 1
TIL Tumor-infiltrating lymphocytes
TKI Tyrosine kinase inhibitors
TNBC Triple-negative breast cancer
TNFα Tumor necrosis factor alpha
TSA Trichostatin A
TSP-1 Thrombospondin 1
VD Vitamin D
VD3 Vitamin D3
VDR Vitamin D receptor
VDREs Vitamin D response elements
VEGF Vascular endothelial growth factor